Reshoring Debate Continues As COVID-19 Drives New Wave Of US Drug Shortages

 
• By Shannon Brown
  
COVID-19-related manufacturing has led to shortage of critical drugs • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Manufacturing

More from Compliance